Page last updated: 2024-08-23

nigericin and Fatty Liver, Nonalcoholic

nigericin has been researched along with Fatty Liver, Nonalcoholic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Guan, Q; Han, C; Li, W; Ruan, S; Sheng, Y; Wang, J; Yang, Y; Zhang, C; Zhou, X1
Chen, CY; Chen, HW; Lii, CK; Lo, CW; Yen, CC1

Other Studies

2 other study(ies) available for nigericin and Fatty Liver, Nonalcoholic

ArticleYear
Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
    International immunopharmacology, 2021, Volume: 100

    Topics: Animals; Caspase 1; Cell Survival; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Inflammasomes; Inflammation; Interleukin-1beta; Kupffer Cells; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Pyroptosis; Steroids

2021
Benzyl isothiocyanate attenuates activation of the NLRP3 inflammasome in Kupffer cells and improves diet-induced steatohepatitis.
    Toxicology and applied pharmacology, 2023, 03-01, Volume: 462

    Topics: Animals; Cholesterol; Diet, High-Fat; Inflammasomes; Inflammation; Insulin Resistance; Interleukin-1beta; Kupffer Cells; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease

2023